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1. Introduction 
Cardiac development is a highly ordered process that involves several steps whose features 
are conserved from insects to vertebrates. In the mouse, two distinct mesodermal heart 
fields with a common origin contribute to heart development in a temporally and spatially 
specific manner (Buckingham et al. 2005). Heart progenitor cells located in the primitive 
streak migrate anteriorly and spread laterally to form the two paired primary heart fields 
(FHFs). Mesodermal precursors for heart-forming cells express initially Brachyury T, a T-
box transcription factor, and lately, at the precardiac stage, the mesoderm posterior 1 
(Mesp1) marker (Solloway and Harvey 2003). Later in development, cardiac precursors 
coalesce into the linear heart tube and ultimately give rise to the left ventricle of the mature 
four-chambered mammalian heart. The secondary heart field (SHF) is instead derived from 
cells of the pharyngeal and the splanchnic mesoderm that will migrate into the developing 
heart and give rise to the right ventricle, the outflow tract, and portions of the inflow tract 
(Chien et al. 2008). FHF and SHF are characterized by the expression of specific genes: the T-
box protein tbx5 and the first wave of Nkx2.5 appear to be restricted to derivatives of the 
FHF (Bruneau et al. 2001; Zaffran et al. 2004; Buckingham et al. 2005), whereas SHF is marked 
by the expression of the LIM domain homeobox gene isl1, or the second wave of Nkx2.5 
(Kelly et al. 2001; Cai et al. 2003). Finally cardiomyocyte progenitor cells that contribute to 
the atrial and ventricular myocardium have been identified also within the epicardium, and 
are marked by the expression of either Wt1 or Tbx18 (Cai et al. 2008; Zhou et al. 2008).  
Instructions for cardiac commitment derive from neighboring embryonic tissues (Abu-Issa 
and Kirby 2007). Cell commitment occurs in two stages: specification and determination. 
While a cell is specified if it differentiates toward the definitive lineage in a neutral 
environment, it is determined if it differentiates in an antagonistic environment.  Cardiac 
specification factors include activin or Transforming Growth Factor (TGF)-β while bone 
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morphogenetic proteins (BMPs) and FGFs are considered as determination factors (Ladd et 
al. 1998). These inductive signals, summarized in Fig. 1, are released in a precisely timed and 
spatially regulated fashion (Zaffran and Frasch 2002). Generally, endoderm-derived signals 
act as inducers of cardiac mesoderm formation, while ectoderm secretes inhibitory factors.  
Pro-cardiogenic molecules comprise specification factors, determination factors, which 
includes Wnt/b-catenin, TGF-ß family, Bone Morphogenetic Proteins (BMPs) and Cripto, 
Sonic Hedgehog, Crescent (Harvey 2002; Foley and Mercola 2004). 
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Fig. 1. Schematic diagram of cardiogenic inhibitors and inducers 
At variance, myocardial differentiation is inhibited by Notch and by canonical Wnt signal 
through β-catenin (for a complete overview of the cardiac developmental process see (Kirby 
2007). However, the scenario of the heart inducer morphogens is still incomplete, and several 
hints may come from in vitro study of the embryonic stem cell (ESC) differentiation process.  
Since ESCs possess the ability to give rise to all cell lineages (Nishikawa et al. 2007), they 
represent a powerful approach to elucidate the origin and the molecular identity of the 
cardiovascular progenitor populations. Indeed, all the cells belonging to the cardiovascular 
lineage have been generated in the embryoid bodies (EBs) formed during in vitro ESCs 
differentiation protocol and gene expression analysis suggest that their development in 
culture recapitulates cardiogenesis in the early embryo (Boheler et al. 2002).  
ESCs are a promising tool in cellular therapy for the repair of injured myocardium. Heart 
failure represents a major cause of death and hospitalization in Western countries. Because 
of the limited capacity of mammalian heart to regenerate, the lonely therapy for CM loss is 
cardiac transplantation. However, the possibility to replace damaged heart tissue with cells 
capable of in situ differentiation and of myocardial integration is very attractive. Indeed the 
identification, isolation, and characterization of murine ESC (mESC)-derived cardiac 
progenitor cells (CPCs) on the basis of Brachyury/Flk1 (Kattman et al. 2006), 
Isl1/Flk1/Nkx2-5 (Moretti et al. 2006), cKit/Nkx2-5 (Wu et al. 2006), or Nkx2-5 (Christoforou 
et al. 2008) expression, has been recently reported by several groups. These cells represent a 
promising source for heart repair because of their restricted capacity to differentiate into 
cardiac muscle, smooth muscle, and vascular endothelium (Kattman et al. 2006; Moretti et al. 
2006; Wu et al. 2006; Christoforou et al. 2008). Indeed, when injected in infarcted area of 
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murine heart, CPCs engrafted and differentiated into CMs, as well as contributed to 
neovascularization, thus improving the cardiac function of treated animals (Christoforou et 
al. 2010). 
As stated before, the in vitro differentiation process of mESC mostly recapitulates the 
embryonic development and indeed CMs derived from mESC resemble beating cells of the 
embryonic heart tube (Fijnvandraat et al. 2003). By combining several data, the cardiac 
differentiation process can be traced relying on the expression of molecular markers (Fig. 2).  
The cardiogenic mesoderm will give rise to a cardiovascular precursor (CVP) population 
characterized by the expression of Flk1, Nkx2.5, Isl1, and c-kit. From these cells 
cardiomyocyte progenitors, as well as precursors of endothelial and smooth muscle cell 
lineages, will originate. Cardiomyocyte progenitors, identified by Nkx2.5, Gata4, and Mef2c 
expression, will afterwards differentiate into functional mature CMs, characterized by the 
appearance of specific structural proteins, e.g. myosin heavy chain (MHC)-α, -β, and the 
ventricular myosin Myl2. 
Cardiomyocyte development in ESC differentiation cultures is well established and is easily 
detected by the appearance of areas of spontaneously contracting cells (beating foci) that 
display characteristics of mature CMs (Sachinidis et al. 2003). Beating cells are absent if the 
genetical manipulation of ESCs abrogates the expression of a gene involved in CM 
differentiation. The study of knocked-out ESCs has lead to the discovery of several genes, 
whose contribution to cardiogenesis could not be assessed in mice because of the early 
embryonic lethality. Indeed, the absence of EphB4 (Wang et al. 2004), Cripto-1 (Xu et al. 
1998), Shp-2 (Qu and Feng 1998), FGFR1 (Dell'Era et al. 2003), Sik1 (Romito et al. 2010)., 
JSAP1 (Sato et al. 2005), and the overexpression of a constitutively active Rac (Puceat et al. 
2003), severely impaired the appearance of beating foci. Due to the complexity of events, the 
blockade of cardiac differentiation can occur either in different step of CM differentiation or 
in cell lineages that secrete cardiac specification/determination peptides. Indeed, has been 
recently shown that the absence of CM differentiation in EphB4-/- mESC can be rescued by 
EphB4+, CD31+ endothelial cells (Chen et al. 2010). 
In this review we will focus on two selected membrane receptor systems, FGFR1 and Cripto, 
both of them involved in cardiac mesoderm formation and patterning at different levels, 
whose contribution to murine early cardiac development has been established by studying 
mESC differentiation cultures. 
2. Cripto 
Cripto is the original member of a family of vertebrate signaling molecules, the EGF-CFC 
family (Ciccodicola et al. 1989) which includes human, mouse and chick Cripto; human and 
mouse Cryptic, Xenopus FRL-1 and Zebrafish OEP (one eyed-pinhead) (Shen and Schier 
2000). Initially described as secreted molecules, members of this family are extracellular 
membrane proteins, anchored to the lipid bilayer through a glycosilphosphatidylinositol 
(GPI) moiety (Minchiotti et al. 2000). 
Early studies of cripto were focused on its possible role in cell transformation and tumor 
progression (Salomon et al. 1999; Persico et al. 2001). Cripto expression was first found in 
human and mouse embryonal carcinoma cells and male teratocarcinomas and was 
demonstrated to be over-expressed in breast, cervical, ovarian, gastric, lung, colon and 
pancreatic carcinomas, in contrast to normal tissues where cripto expression was invariably 
absent (Strizzi et al. 2005).  
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In mouse embryos, cripto is expressed early in the ICM and the throphoblast cells of the 
blastocyst (Johnson et al. 1994). At 6.5 dpc cripto is expressed in the epiblast and at the 
primitive streak stage in the forming mesoderm. Later on, cripto expression is associated 
with the developing heart structures; its expression is restricted to the myocardium of the 
developing heart tube at 8.5 dpc and in the outflow region of the heart at 9.5 dpc (Dono et al. 
1993). This expression pattern suggests that cripto may play a role in the early events leading 
to heart morphogenesis. Mouse embryos deficient for the cripto gene die around day 7.5 of 
embryogenesis due to defects in mesoderm formation and axial organization (Ding et al. 
1998; Liguori et al. 2003). Notably, mouse cripto mutants exhibit defects in myocardial 
development as evidenced by the absence of expression of terminal myocardial 
differentiation genes such as MHC and MLC2v (Ding et al. 1998; Xu et al. 1999a).  
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Fig. 2. Schematic illustration of cardiomyocyte development. Adapted from Chen et al., 2008 
Given the early lethality of cripto-/- mice, ESCs have been a powerful tool to shed light into 
the functional role of cripto in mammalian cardiomiogenesis. Indeed, by using EBs derived 
from Cripto-/- ES cells, it has been demonstrated that genetic ablation of cripto block cardiac 
differentiation (Xu et al. 1998) and that forced expression of wild-type cripto fully rescues the 
cardiac phenotype, thus providing  experimental evidence of a functional role of this gene in 
mammalian cardiomyogenesis. Interestingly, a structure function analysis using different 
deletion mutant derivatives of cripto cDNAs showed that i) a secreted form of Cripto, which 
lacks the C-terminus, is capable of retaining its biological activity and efficiently induces 
cardiogenesis and ii) the EGF-CFC domain represents the minimal functional domain, 
which is sufficient per sè to restore cardiac differentiation of Cripto-/- ES cells (Parisi et al. 
2003). Worth noting, the EGF-like domain, which was previously shown to be mitogenic on 
mammary cell lines (Salomon et al. 1999), although essential, it is not sufficient per sè to 
promote cardiac differentiation, suggesting that there may be divergent Cripto signaling 
pathways depending both on different domains of the protein and/or on specific cell types, 
an issue that still remains undefined.  
Another important issue was the timing of initiation, the strength and duration of Cripto 
signaling in the commitment of ESCs to a cardiac fate, which was experimentally addressed 
by using a recombinant secreted Cripto protein. Infact, kinetic experiments performed by 
adding recombinant Cripto to the culture medium of Cripto-/- ES cells indicate that Cripto is 
required in a precise moment during differentiation after which it fails to specify the cardiac 
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lineage. Moreover, a transient presence of Cripto protein is inefficient and a sustained 
Cripto signaling is strictly required to promote cardiogenesis; thus providing evidence that 
timing and strength of the signaling are critical parameters for correct specification and 
differentiation of the cardiac lineage (Parisi et al. 2003). 
Both the functional data and the expression profile of Cripto, which is expressed early 
during cardiac differentiation of ESCs (i.e., day 0-4) while is absent at stages where 
contracting cardiomyocites appear, indicate that Cripto is required for cardiac commitment 
of ESCs rather than for terminal differentiation of cardiomyocytes in culture.  
Intriguingly, disruption of cripto leads to spontaneous neuronal differentiation of ESCs in 
the presence of serum, and in the absence of either specific inducers or defined culture 
conditions. Again, kinetic experiments indicate that the timing of Cripto signaling required 
for priming ESCs to cardiomyocytes resembles the competence window those cells to 
acquire a neural fate (Parisi et al. 2003). Indeed, addition of effective doses of Cripto protein 
to Cripto-/- ESCs in the 0-2 day interval of differentiation rescues the cardiac phenotype and 
results in a dramatic inhibition of neural differentiation. Conversely, addition of 
recombinant Cripto at later time points (i.e 3-6 day interval) results in progressive 
impairment of cardiac differentiation, and in increased competence of the cells to acquire a 
neural fate; thus suggesting that different timing of Cripto signaling induces different fates 
in ESCs.  
2.1 Cripto/Smad2 signaling pathway in cardiomyogenesis 
Cripto is involved in the modulation of several signaling pathways in development and 
tumorigenesis (Strizzi et al. 2005). Genetic studies and cell-based assays provide evidence for 
a role of Cripto and, more generally of the EGF-CFC factors, in the activation of the TGFβ-
family member Nodal or related ligands GDF1 and -3 (Chen et al. 2006; Tanaka et al. 2007) 
through Activin type IB (ALK-4 and Alk7) and Activin type IIB serine/threonine kinase 
(ActRIIB) receptors (Reissmann et al. 2001). Upon receptor activation, the intracellular kinase 
domain of the type I receptor phosphorylates Smad2 and/or Smad3, which form a 
hexameric complex with the common Smad4, and translocate into the nucleus to regulate 
gene expression in conjunction with other transcription factors, such as FoxH1 (Massague 
and Chen 2000; Adkins et al. 2003; Gray et al. 2003; Harrison et al. 2005).  
Notably, acute stimulation of Cripto-/- ESCs with recombinant Cripto protein rapidly 
induces Smad2 phosphorylation; thus although competent in activating Smad2, transient 
stimulation with Cripto is insufficient to achieve proper terminal cardiac differentiation, 
again highlighting the importance of Cripto signalling duration for cardiomyogenesis (Parisi 
et al. 2003). 
 Intracellular activation of Smad2 upon stimulation with Cripto, requires assembly of an 
active activin type I (ALK4) and type II receptor complex. In fact, forced overexpression of 
the activated forms of ALK-4 receptor are able to compensate for the lack of Cripto in 
cardiac differentiation. Moreover, loss-of-function experiments performed using Nodal 
antagonist, Cerberus-S, provide direct evidence that the TGF-β family member Nodal is 
required to support Cripto-regulated cardiac induction and differentiation in ES cells. Infact, 
addition of Cerberus Short protein, which specifically blocks Nodal by direct binding to the 
ligand (Piccolo et al. 1999) results in a strong inhibition of Cripto activity in ESCs (Parisi et al. 
2003). 
Besides the above mentioned data, several other line of evidence support the idea that 
temporal and spatial regulation of the Smad pathway is important for normal cardiac 
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development from initial cardiomyocyte differentiation to terminal cardiac morphogenesis 
in pluripotent cells. In fact, data on P19 cells indicate that the Smad pathway is 
indispensable for normal cardiomyocyte differentiation (Monzen et al. 2001). Moreover, 
more recent data pointed for a key role of Nodal/Cripto for the early activation of Smad2, 
which was indispensable for mesendodermal induction and the subsequent cardiac 
differentiation of ESCs (Kitamura et al. 2007). 
2.2 Downstream targets of Cripto signaling in cardiomyogenesis 
It is now well accepted that Cripto/Smad2 is one of the key signaling pathway which 
regulates cardiac specification in mammals; however, little is yet known about the 
mechanisms of action and the identity of the factors downstream of this pathway in 
mammalian cardiomyogenesis. Very recently, two genes, the Angiotensin Type-I Like 
Receptor (AGTRL-1/APJ/msr1) and its ligand apelin, have been identified as previously 
undescribed downstream targets of Cripto-Smad2 pathway in cardiogenesis (D'Aniello et al. 
2009). 
Apj was identified and characterized in 1993 as a seven transmembrane receptor associated 
with G-proteins (O'Dowd et al. 1993); it shows a high sequence homology (30%) with 
angiotensin II type 1 receptor (AT-1), although APJ does not bind angiotensin II (AngII). Apj 
was kept “orphan” until 1998 when Tatemoto et al. identified Apelin as its selective 
endogenous ligand. Apelin is a prepropeptide of 77 aminoacids but its biological activity 
resides in the C-terminus (apelin-36 and apelin-13) (Tatemoto et al. 1998). 
In the adult, Apelin and Apj are abundantly expressed in the heart, the central nervous 
system (CNS) and the lungs (Kawamata et al. 2001; Medhurst et al. 2003). The wide 
distribution of Apj and apelin in several organs correlates with multifunctional activities, 
such as the regulation of gastrointestinal and immune functions, the modulation of the 
hypothalamus-hypophysis axis activity and the regulation of vascular tone, cardiac 
contractile function and fluid balance (Kleinz and Davenport 2005). 
Most remarkably, growing evidence indicate that apelin and APJ play an important role in 
cardiac development both in Xenopus (Inui et al. 2006; Cox et al. 2006) and in Zebrafish (Scott 
et al. 2007; Zeng et al. 2007). Indeed, under or over expression of apelin-APJ signalling results 
in a reduction in cardiomyocyte numbers and abnormal cardiac morphology (Scott et al. 
2007; Zeng et al. 2007). 
Notably, the expression of Apj and apelin i) correlates with that of cripto both in ESC 
differentiation and in gastrulating embryos and ii) is regulated by Cripto/Smad2 pathway 
in ESCs. Indeed, Apj and apelin expression is dramatically reduced in the absence of cripto 
(D'Aniello et al. 2009) both in ESC cardiac differentiation and in vivo. Most remarkably, APJ 
overexpression is capable of redirecting the neuronal fate of cripto knockout ESCs, restoring 
mesendodermal patterning and the cardiogenic program, although it fails to induce beating 
EBs. Finally, both apelin and Apj silencing blocks cardiac differentiation, thus pointing out a 
central role of APJ/Apelin in the gene regulatory cascade promoting cardiac specification 
and differentiation in ESCs (D'Aniello et al. 2009). 
One of the major transduction pathways activated by Apelin depends on the interaction 
with a Gi-protein coupled to the Apj receptor with the subsequent interaction with the 
protein Kinase C (PKC) (Masri et al. 2004). Morever, apelin activates the phosphorylation of 
the intracellular kinase p70S6K through a pertussis toxin (PTX) sensitive G protein (Masri et 
al. 2002). Data on primary endothelial cells indicate that stimulation of p70S6K by Apelin 
depends on two mechanisms, which are either ERK or PI3K/Akt-dependent (Masri et al. 
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2004). In line with these findings, Apelin induces mammalian cardiomyogenesis via a PTX-
sensitive GTP binding protein associated to Apj receptor, through the activation of  
ERK-dependent p70S6K signaling pathway (D'Aniello et al. 2009). 
3. FGFR1 
The FGF/FGFR system has been implicated in a variety of physiological and pathological 
conditions, including embryonic development, tissue growth and remodeling, 
inflammation, tumor growth and vascularization (Powers et al. 2000; Presta et al. 2005). 
FGFR1 is one of the four member of the FGFR family, whose amino acid sequence is highly 
conserved between members and throughout evolution (Itoh and Ornitz 2004). FGFRs differ 
from one another in their ligand affinities and tissue distribution. A full-length 
representative protein consists of an extracellular region, composed of three 
immunoglobulin-like domains (D1-D3), a single hydrophobic transmembrane region and an 
intracellular tyrosine kinase (TK) domain (Beenken and Mohammadi 2009). The ligand 
binding site for FGFs is located in the D2-D3 domains and the linker that connects them 
(Plotnikov et al. 2000), whereas the D1 domain is involved in receptor autoinhibition (Olsen 
et al. 2004). Ligand specificity is achieved primarily through splicing events in which the 
alternative exons IIIb and IIIc encode the carboxyl terminal portion of the third Ig-like loop. 
Indeed, alternative splicing of FGFR1 results in isoforms FGFR1-IIIb and FGFR1-IIIc with 
distinct FGF binding characteristics: FGFR1-IIIb binds efficiently to FGF1, FGF3 and FGF 10, 
whereas FGFR1-IIIc binds to FGF1, FGF2, FGF4, FGF6, FGF8 and FGF9 (Ornitz et al. 1996). A 
variety of other alternative spliced receptor molecules have been described, including the β 
isoforms that lack the first Ig-like domain whereas the  isoforms identify the full-length 
receptors (Wang et al. 1995). 
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Fig. 3. Mesodermal marker expression by qPCR analysis in fgfr1+/- and fgfr1-/- EBs 
FGFR1 signaling plays important functions in mesoderm formation and development (Xu et 
al. 1999b). Heterozygous animals develop normally but fgfr1-/- mice dye during gastrulation, 
displaying defective mesoderm patterning with reduction in the amount of paraxial 
mesoderm and lack of somite formation (Deng et al. 1994; Yamaguchi et al. 1994). Studies on 
chimeric embryos using FGFR1-deficient mESC revealed an early defect in the mesodermal 
and endodermal cell movement through the primitive streak, followed by deficiencies in 
contributing to anterior mesoderm, including heart tissue (Ciruna et al. 1997; Deng et al. 
1997). We analyzed early mesodermal marker expression during the first days of mESC 
differentiation and indeed, Brachyury, Mesp1, Mesp2, and Mef2c genes are strongly 
 Embryonic Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis 
 
494 
upregulated in fgfr1-/- compared to fgfr1+/- mESC (Fig. 3). Although we still don’t know the 
significance of this upregulation, we can confirm a bias in mesodermal lineage development 
also in the mESC differentiation model.  
The pivotal contribution of FGF signaling in heart formation has been demonstrated in 
different animal models: in C. intestinalis, FGF signaling delineates the cardiac progenitor 
field (Davidson 2007); in Drosophila, mesoderm spreading depends upon the expression of 
heartless, homologous to vertebrate fgfr1 (Beiman et al. 1996; Gisselbrecht et al. 1996), and 
heartless mutant is characterized by the absence of the heart (Frasch 1995; Beiman et al. 1996); 
in chicken, FGF signaling activated by FGF8 contributes to the heart-inducing properties of 
the endoderm (Alsan and Schultheiss 2002); in zebrafish, induction and differentiation of the 
heart requires FGF8 (Reifers et al. 2000); in mice, Fgf8neo/– mutants show complex cardiac 
defects (Abu-Issa et al. 2002). 
FGFR1 has been implicated in cardiac development also during mESC differentiation. When 
fgfr1-/- mESC were differentiated with the “hanging drop” protocol, no beating foci were 
seen in EB cultures within the first fourteen days, whereas contracting areas were observed 
microscopically in more than 90% of the heterozygous EBs at day 8th. To verify the 
morphological data, total RNA was extracted at different time point of differentiation, and 
then subjected to retrotranscription, and semiquantitative polymerase chain reaction (PCR) 
for cardiac marker expression.  In parallel, EBs were fixed, paraffin included, cut in 7μM 
sections, and analyzed by immunofluorescence for the presence of the structural protein 
MHC-α. Both methods confirmed the presence of cardiac markers lonely in fgfr1+/- mESC, 
thus indicating that the beating areas indeed correspond to CMs, whose differentiation 
depends upon FGFR1 expression (Dell'Era et al. 2003). 
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Fig. 4. Heart field marker expression by qPCR analysis in fgfr1+/- and fgfr1-/- EBs 
Nkx2.5 is considered the earliest cardiac transcription factor because of its expression in 
cardiovascular precursors and the mRNA analysis of fgfr1-/- EBs showed that the absence of 
FGFR1 does not allow Nkx2.5 upregulation (Dell'Era et al. 2003; Ronca et al. 2009). This 
result suggest that fgfr1-/- EBs cannot make the transition to develop cardiac lineage from 
cardiogenic mesoderm, and indeed, Mesp1, Mesp2, and Mef2c accumulation suggests a 
flooding of mesodermal precursors. As mentioned, Nkx2.5+ CVP can give rise to CMs, 
endothelial, and smooth muscle cells (Chen et al. 2008). However, CD31 and α-smooth 
muscle actin immunostaining of EBs showed that differentiation of endothelial and smooth 
muscle cells is not affected by the lack of FGFR1 (Magnusson et al. 2004). Indeed, the 
vascular plexus in fgfr1-/- EBs is more abundant to that observed in heterozygous EBs, thus 
suggesting that the cells that cannot become CMs are forced toward parallel lineages, such 
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as endothelial cells. FGFR1 was first isolated by a endothelial cell cDNA library due to its 
homology with the tyrosine kinase receptor Fms (Dionne et al. 1990), and both the prototype 
FGFs (FGF1 and FGF2) are considered as angiogenic growth factors (Presta et al. 2005). Then, 
it was really surprising to realize that the receptor was not really involved in endothelial 
development. However, as suggested by immunostaining of EBs with an antibody specific 
for the activated receptor, FGFR-1 is phosphorylated in a subpopulation of proliferating 
endothelial cells (Magnusson et al. 2005), thus confirming its role in endothelial cell 
proliferation rather than differentiation. 
It has previously shown that FGFR-1 is required by epicardium-derived cells for myocardial 
invasion (Pennisi and Mikawa 2009), and that mature CMs expressing FGFR1 proliferate 
upon receptor stimulation (Seyed and Dimario 2008). Then, the open question if FGFR1 is 
expressed by cardiogenic precursors and/or by other mesodermal cells and why is it needed 
during mESC CM differentiation is still controversial. To add a little piece to the puzzle, we 
analyzed FHF and SHF markers in fgfr1-/- EBs and the results are reported in Fig. 4.  
When compared with heterozygous EBs, both nkx2.5 and FGF10 genes do not show any 
upregulation during fgfr1-/- mESC differentiation, while a smaller increase can be seen for 
Tbx5; at variance, the SHF marker Isl1 seem to be comparable between the two populations, 
thus suggesting that the absence of FGFR1 results in a bias in primary heart field 
development. It should be pointed out that one of the limitation of the mESC model is that it 
is impossible to dissect anatomical structures of the EBs; this fact imply that cells 
anatomically distant can be found in close proximity, thus leading to artificial paracrine 
stimulations affecting the “normal” development. Taking together, our data suggest that 
FGFR1, probably present on cardiomyocyte precursor cell surface, may mediate 
cardiomyocyte differentiation by activating Nkx2.5 in Mef2c-cardiogenic mesodermal cells. 
Indeed, in other models FGF signaling has been shown to be sufficient to induce cardiac 
transcription factor expression: FGF8-soaked beads induce nkx2.5 in chick (Alsan and 
Schultheiss 2002) and zebrafish (Reifers et al. 2000), whereas an ectopic FGF signaling results 
in a surplus of CMs prior to terminal differentiation (Marques et al. 2008). 
The interaction of FGFR1 with a ligand leads to a cascade of downstream signals, ultimately 
influencing mitogenesis and differentiation. Seven tyrosine residues become 
phosphorylated in human FGFR1 (hFGFR1): Y653/654 are critical for TK activity 
(Mohammadi et al. 1996), Y463 is involved in endothelial cell proliferation by binding to Src 
homology (SH)2/SH3 domain-containing adaptor protein Crk (Larsson et al. 1999), and 
phosphorylated Y766 has been shown to bind phospholipase C-γ(PLC- γ) in L6 myoblasts, 
Shb in endothelial cells, and Grb14 in MDA-MB-231 human breast cancer cells (Mohammadi 
et al. 1991; Cross et al. 2002; Cailliau et al. 2005). Also, FGFR1 activation leads to FRS2 
phosphorylation (Kouhara et al. 1997) followed by Grb2 and Shp-2 interactions (Hadari et al. 
1998). Frs2, Crk, and Shb binding to FGFR1 affect the classical Ras/Raf-1/MEK/ERK/Jun 
proliferation pathway activated by TK receptors, while PLCγ1 activates PKC (Hug and Sarre 
1993), whose role in CM differentiation has been demonstrated (Zhou et al. 2003).  
Previous observation had shown that the FGFR1 TK inhibitor SU 5402 (Mohammadi et al. 
1997), the MEK1/2 inhibitor U0126 (Favata et al. 1998), and the classical/novel protein kinase 
C (PKC) inhibitor GF109203X (Kuchera et al. 1993) were all able to hamper beating foci 
formation in EBs originated by fgfr1+/- mESC (Dell'Era et al. 2003). In order to define the 
requirements for FGFR1 signaling in CM development, we transduced fgfr1-/- mESC via a 
lentiviral vector system with the IIIc isoform of either wt receptor (v-wt-hFGFR1), or 
hFGFR1 mutants in different tyrosine autophosphorylation sites: the tyrosine kinase 
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defective (TK-) Y653/654F-hFGFR1 mutant, and the two TK+ Y463F-, and Y766F-h-FGFR1. 
Resulting cell lines were analyzed to confirm that the receptors were correctly exposed on 
cell surface, by 125I-FGF2 binding assay and, at least for TK+ receptors, were able to 
upregulate the downstream signaling molecule ERK1/2. Then, we evaluated the presence of 
cardiomyocyte during the differentiation process by looking microscopically to the 
appearance of beating foci, and by expression analysis of both early and late cardiac 
markers. We first observed that transduction of the human receptor molecule fully 
reconstitutes cardiomyocyte differentiation, while, in agreement with previous data 
obtained by using pharmacological inhibitors, TK- receptor does not. The analysis of Y463F 
and Y766F mutant EBs demonstrate that v-Y766F-hFGFR1 ES cells are able to support 
cardiomyocyte differentiation in a manner undistinguishable from v-wt-hFGFR1 ES cells 
and fgfr1+/- ES cells. In contrast, transduction of fgfr1-/- ES cells with the Y463F-hFGFR1 
mutant results in a loss of rescue of cardiomyocyte formation, as assessed by the absence of 
beating foci and early and late cardiomyocyte markers in the corresponding EBs (Ronca et al. 
2009).  At present, the signaling cascade triggered by the autophosphorylation of Y463 in 
FGFR1 and its cross-talk with PKC- and ERK-mediated signaling during cardiomyocyte 
differentiation of mESC remains to be elucidated. 
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fgfr1-/- , v-wt-hFGFR1, v-Y463F-hFGFR1, and v-Y653/654F-hFGFR1 ES cells were subjected to standard 
differentiation protocol. At day 9th of differentiation, cell extracts were analyzed for activated signaling 
molecules. 
Fig. 4. Characterization of FGFR1 signalling during ES differentiation. 
Indeed, Western blot analysis of total EB protein extract at day 9 of differentiation does not 
show any difference in CrkII phosphorylation levels among fgfr1-/-, v-wt-hFGFR1, v-Y463F-
hFGFR1 and v-Y653/654F-hFGFR1 EBs, thus indicating that the overall activation of these 
signaling molecules in differentiating EBs is not restricted to FGFR1 activity. Also, FRS2 
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appears to be phosphorylated in both v-Y463F-hFGFR1 and v-wt-hFGFR1 EBs but not in TK- 
v-Y653/654F-hFGFR1 and fgfr1-/- EBs, indicating that its activation depends on the TK 
activity of FGFR1 but not on Y463 phosphorylation. Again, only the isolation of the different 
cardiomyocyte progenitor populations from these EBs will allow the identification of the 
FGFR1-dependent signalling pathway(s) involved in cardiomyocyte differentiation in 
mESC.  
4. Conclusions 
Although ESCs represent a viable source of specific cellular subtypes for drug discovery and 
transplantation, the successful use of ES-derived donor cells would require the generation of 
essentially pure cultures of specific cell types. Although further analysis will be required to 
get insight into the regulatory networks that involve Cripto/APJ and FGFR1 in cardiac 
differentiation (Figure 5), these membrane receptors may represent valuable targets for the 
generation of pure cardiomyocyte populations from ESCs. 
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Fig. 5. Cripto/Apelin and FGFR1 influence the early phases of cardiomyocyte differentiation 
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